Combination therapy (Provigil [modafinil] + Avonex [interferon-beta-1a] in the treatment of attention problems in patients with relapsing-remitting MS [multiple sclerosis]

Trial Profile

Combination therapy (Provigil [modafinil] + Avonex [interferon-beta-1a] in the treatment of attention problems in patients with relapsing-remitting MS [multiple sclerosis]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Interferon beta-1a (Primary) ; Modafinil (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top